Linden Thomas Advisory Services’s Chemours CC Stock Holding History

Linden Thomas Advisory Services’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$424K	Sell	20,664 -21	-0.1%	-$481	0.03%	423
2026 Q1	$456K	Buy	20,685 +1,065	+5%	+$18.5K	0.04%	391
2025 Q4	$231K	Sell	19,620 -921	-4%	-$11.8K	0.02%	465
2025 Q3	$325K	Buy	20,541 +545	+3%	+$7.91K	0.03%	411
2025 Q2	$229K	Sell	19,996 -149	-0.7%	-$1.68K	0.03%	461
2025 Q1	$273K	Buy	20,145 +259	+1%	+$4.3K	0.04%	426
2024 Q4	$336K	Sell	19,886 -402	-2%	-$7.82K	0.04%	417
2024 Q3	$412K	Sell	20,288 -112	-0.5%	-$2.29K	0.06%	391
2024 Q2	$460K	Buy	+20,400	New	+$534K	0.07%	367

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Linden Thomas Advisory Services's CC Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its Chemours (CC) stake by 0.1% in Q2 2026, selling an estimated $481 and leaving 20,664 shares worth $424K. The position accounts for 0.03% of the portfolio, ranked #423.

Linden Thomas Advisory Services first reported a position in CC in Q2 2024 and has held it in 9 quarters since. The position peaked at $460K in Q2 2024. 472 funds tracked by Wall St. Rank hold CC as of Q2 2026.

Linden Thomas Advisory Services held 20,664 shares of Chemours worth $424K as of Q2 2026.
Linden Thomas Advisory Services sold 21 Chemours shares in Q2 2026, an estimated $481.
Chemours made up 0.03% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #423 holding.
Linden Thomas Advisory Services first reported a position in Chemours in Q2 2024 and has held it in 9 quarters since.
Linden Thomas Advisory Services's Chemours position peaked at $460K in Q2 2024.
472 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.